Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
119,109,134
-
Share change
-
+15,798,425
-
Total reported value
-
$3,513,732,753
-
Put/Call ratio
-
32%
-
Price per share
-
$29.50
-
Number of holders
-
92
-
Value change
-
+$482,150,677
-
Number of buys
-
70
-
Number of sells
-
30
Institutional Holders of CEREVEL THERAPEUTICS HLDNG I - COM (CERE) as of Q3 2021
As of 30 Sep 2021,
CEREVEL THERAPEUTICS HLDNG I - COM (CERE) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
119,109,134 shares.
The largest 10 holders included
Bain Capital Investors LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., ALKEON CAPITAL MANAGEMENT LLC, FEDERATED HERMES, INC., STATE STREET CORP, and Artal Group S.A..
This page lists
92
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.